Skip to main content
. 2019 Mar 7;10:174. doi: 10.3389/fneur.2019.00174

Table 1.

Patient characteristics.

Subject no. Age (years, range) Disease duration (years) H&Y stage Clinically worse side L-Dopa ED (mg/d) MMSE BDI
1 70–80 2 2 Left 550 30 5
2 70–80 4 2 Right 0 30 2
3 50–60 7 2 Right 310 30 6
4 50–60 10 2 Right 560 29 2
5 40–50 11 2 Left 1,092 29 7
6 70–80 10 2 Left 550 30 3
7 60–70 9 2 Right 1,220 28 4
8 40–50 9 2 Right 730 28 10
9 50–60 5 3 Left 580 28 17
10 70–80 6 3 Right 600 29 7
11 40–50 3 2 Left 600 30 14
12 60–70 10 2 Right 845 28 0
13 60–70 5 2 Right 500 29 3
14 20–30 10 2 Right 275 30 12
15 70–80 17 3 Left 450 28 3
16 20–30 14 1 Right 300 30 13
17 60–70 19 2 Left 240 28 1
18 60–70 4 2 Right 610 29 7
19 60–70 9 2 Left 880 24 4
20 50–60 1 1 Right 254 30 3
M ± SD 58.5 ± 14.1 12.8 ± 20.9 557 ± 297 28.9 ± 1.4 6.2 ± 4.7

H&Y stage, Hoehn and Yahr stage; ED, equivalence dose; MMSE, Mini-Mental State Examination; BDI, Beck Depression Inventory. Units, disease duration and age in years; L-Dopa ED in mg/d. M, mean; SD, standard deviation.